Month: October 2020
-
Carb-X Funding Nanoscale Sponge to Treat Sepsis
A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment.
-
Growing your Small Business Slowly is Super Important
Make sure that you don’t grow too quickly or you may end up stunting your own success.
-
Software Designed to Model, Visualize Brain Circuits
An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits.
-
Covid-19 Vaccine Challenge Trial Underway
Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines.
-
Myeloma Drug Shown to Treat Covid-19 Patients
Results from an early clinical trial show a drug designed to treat multiple myeloma also reduces viral loads and hospital stays of patients with Covid-19 infections.
-
Infographic – Covid-19 Brings Down Carbon Emissions
The chart shows double-digit percentage reductions in carbon dioxide emissions through 31 August for many countries experiencing high Covid-19 infection rates.
-
ALS Drug Shown to Extend Patient Survival
Results of a clinical trial show a drug to treat amyotrophic lateral sclerosis, or ALS, extends patients’ survival by several months and slows decline of their functions.
-
Q3 Venture Funds Inch Up, Early-Stage Deals Drop
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-
Maintaining Your Health Care in the New Normal
Science and technology can help families regain care of their general health and medical care in many ways.